[5] [6] Patients taking diabetes medications should monitor their blood glucose as they would with any dietary change
Patients should avoid self-sourcing and should speak with a licensed provider about safety, legal status, and medically supervised options
The FDA has introduced a "Green List" for IA 66-80, focusing on the "Detention Without Physical Examination of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Bulk Drug Substances." This initiative aims to safeguard against the illegal importation of GLP-1 drug ingredients
Nausea, constipation, reflux, appetite changes, and other GLP-1-related effects can still occur
Jos Miguel Hinojosa-Amaya, Autonomous University of Nuevo Len, Mexico Updates Copyright 2021 Schernthaner-Reiter, Wolf, Vila and Luger
A naturally occurring copper tripeptide that promotes tissue remodeling, wound healing, and collagen synthesis in animal and in vitro studies